Literature DB >> 20577739

Quantitative PET imaging of radioligands with slow kinetics in human brain.

Sandra M Sanabria-Bohórquez, Koen Van Laere.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20577739     DOI： 10.1007/s00259-010-1518-x

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  21 in total

1.  [11C]flumazenil metabolite measurement in plasma is not necessary for accurate brain benzodiazepine receptor quantification.

Authors:  S M Sanabria-Bohórquez; D Labar; P Levêque; A Bol; A G De Volder; C Michel; C Veraart
Journal:  Eur J Nucl Med       Date:  2000-11

2.  Measuring the in vivo binding parameters of [18F]-fallypride in monkeys using a PET multiple-injection protocol.

Authors:  Bradley T Christian; Tanjore Narayanan; Bing Shi; Evan D Morris; Joseph Mantil; Jogeshwar Mukherjee
Journal:  J Cereb Blood Flow Metab       Date:  2004-03       Impact factor: 6.200

Review 3.  Consensus nomenclature for in vivo imaging of reversibly binding radioligands.

Authors:  Robert B Innis; Vincent J Cunningham; Jacques Delforge; Masahiro Fujita; Albert Gjedde; Roger N Gunn; James Holden; Sylvain Houle; Sung-Cheng Huang; Masanori Ichise; Hidehiro Iida; Hiroshi Ito; Yuichi Kimura; Robert A Koeppe; Gitte M Knudsen; Juhani Knuuti; Adriaan A Lammertsma; Marc Laruelle; Jean Logan; Ralph Paul Maguire; Mark A Mintun; Evan D Morris; Ramin Parsey; Julie C Price; Mark Slifstein; Vesna Sossi; Tetsuya Suhara; John R Votaw; Dean F Wong; Richard E Carson
Journal:  J Cereb Blood Flow Metab       Date:  2007-05-09       Impact factor: 6.200

4.  Kinetic analysis of the cannabinoid-1 receptor PET tracer [(18)F]MK-9470 in human brain.

Authors:  Sandra Marina Sanabria-Bohórquez; Terence G Hamill; Karolien Goffin; Inge De Lepeleire; Guy Bormans; H Donald Burns; Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12-24       Impact factor: 9.236

5.  Approaches to quantify radioligands that wash out slowly from target organs.

Authors:  Jussi Hirvonen; Garth E Terry; Christer Halldin; Victor W Pike; Robert B Innis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-05       Impact factor: 9.236

6.  In vivo measurement of density and affinity of the monoamine vesicular transporter in a unilateral 6-hydroxydopamine rat model of PD.

Authors:  Vesna Sossi; James E Holden; Geoffrey J Topping; Marie-Laure Camborde; Rich A Kornelsen; Siobhan E McCormick; Jennifer Greene; Andrei R Studenov; Thomas J Ruth; Doris J Doudet
Journal:  J Cereb Blood Flow Metab       Date:  2007-01-24       Impact factor: 6.200

7.  Identification of extrastriatal dopamine D2 receptors in post mortem human brain with [125I]epidepride.

Authors:  R M Kessler; W O Whetsell; M S Ansari; J R Votaw; T de Paulis; J A Clanton; D E Schmidt; N S Mason; R G Manning
Journal:  Brain Res       Date:  1993-04-23       Impact factor: 3.252

8.  Kinetic modelling using basis functions derived from two-tissue compartmental models with a plasma input function: general principle and application to [18F]fluorodeoxyglucose positron emission tomography.

Authors:  Young T Hong; Tim D Fryer
Journal:  Neuroimage       Date:  2010-02-13       Impact factor: 6.556

9.  SPECT quantification of [123I]iomazenil binding to benzodiazepine receptors in nonhuman primates: I. Kinetic modeling of single bolus experiments.

Authors:  M Laruelle; R M Baldwin; Z Rattner; M S al-Tikriti; Y Zea-Ponce; S S Zoghbi; D S Charney; J C Price; J J Frost; P B Hoffer
Journal:  J Cereb Blood Flow Metab       Date:  1994-05       Impact factor: 6.200

10.  Quantification of benzodiazepine receptors in human brain using PET, [11C]flumazenil, and a single-experiment protocol.

Authors:  J Delforge; S Pappata; P Millet; Y Samson; B Bendriem; A Jobert; C Crouzel; A Syrota
Journal:  J Cereb Blood Flow Metab       Date:  1995-03       Impact factor: 6.200
View more
  2 in total

1.  Unexpectedly high affinity of a novel histamine H(3) receptor antagonist, GSK239512, in vivo in human brain, determined using PET.

Authors:  S Ashworth; A Berges; E A Rabiner; A A Wilson; R A Comley; R Y K Lai; R Boardley; G Searle; R N Gunn; M Laruelle; V J Cunningham
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

2.  A pharmacokinetic PET study of NK₁ receptor occupancy.

Authors:  Stefano Zamuner; Eugenii A Rabiner; Sofia A Fernandes; Massimo Bani; Roger N Gunn; Roberto Gomeni; Emilangelo Ratti; Vincent J Cunningham
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-10-13       Impact factor: 9.236
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.